Current position:Home >Product >
1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-(954397-95-6)
- Name: 1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
- Synonyms:
- Molecular Formula:
- Molecular Weight:560.652
- CAS Registry Number:954397-95-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.954397-95-6 1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.954397-95-6 1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 116314-66-0/2-Propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-dimethyl-
- 135017-30-0/Propanedinitrile, 2-[1-[2-[[[5-(1-piperidinylmethyl)-2-furanyl]methyl]amino]ethyl]-2-imidazolidinylidene]-
- 1100749-38-9/1,3-Benzenedicarbonitrile, 5-[[1,4-diethyl-2-(2-hydroxyethyl)-1H-imidazol-5-yl]oxy]-
- 862541-45-5/PF 610355
- 652990-07-3/Milveterol
- 804518-03-4/Milveterol hydrochloride
- 503068-34-6/Vilanterol
- 623152-17-0/BMS 582949
- 1247028-61-0/2H-Indol-2-one, 3-cycloheptyl-1,3-dihydro-3-(4-hydroxyphenyl)-6-methoxy-7-methyl-, (3S)-
- 1064684-44-1/Sofosbuvir
- 260270-37-9/6,9-Imino-5H-cyclohepta[c]pyridine, 6,7,8,9-tetrahydro-, (6R,9S)-
- 934995-87-6/MK-0952
- 934995-88-7/Cyclopropanecarboxylic acid, 2-[3'-[3-[(cyclopropylamino)carbonyl]-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro[1,1'-biphenyl]-4-yl]-, sodium salt (1:1), (1R,2R)-
- 346629-30-9/6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE
- 778625-65-3/MK-0489
- 870615-40-0/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-
- 870615-43-3/6H-[1,2,4]Triazolo[4,3-a][1,5]benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-
- 305366-98-7/GI 181771
- 221671-61-0/SR 146131
- 954397-95-6/1-Naphthalenecarboxylic acid, 3-[4-[[1-(3-ethoxyphenyl)-2-(4-methylphenyl)-1H-imidazol-4-yl]carbonyl]-1-piperazinyl]-
- 1197160-28-3/Urea, N-[4-[4-(4-morpholinyl)-6-(3-oxa-8-azabicyclo[3.2.1]oct-8-yl)-1,3,5-triazin-2-yl]phenyl]-N'-4-pyridinyl-
- 897367-47-4/DP-802
- 897371-87-8/DP-1376
- 331758-35-1/T-226296
- 427878-02-2/Pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide, N-ethyl-4-[[5-[(methoxyamino)carbonyl]-2-methylphenyl]amino]-5-methyl-
- 887702-61-6/1H-Pyrazole-5-heptanoic acid, 1-(4-fluorophenyl)-b,d-dihydroxy-4-(1-methylethyl)-3-[[[(4-methylphenyl)methyl]amino]carbonyl]-, sodium salt (1:1), (bR,dR)-
- 887701-48-6/1H-Pyrazole-5-heptanoic acid, 1-(4-fluorophenyl)-b,d-dihydroxy-4-(1-methylethyl)-3-[[[(4-methylphenyl)methyl]amino]carbonyl]-, (bR,dR)-
- 724444-40-0/Ethanediamide, N1-[(10S)-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-4,6,7,8,9,10-hexahydro-3-hydroxy-4-oxopyrimido[1,2-a]azepin-10-yl]-N1,N2,N2-trimethyl-
- 226878-01-9/NPS 2390
- 440124-11-8/2-Pyrazinecarbonitrile, 6-ethyl-5-methyl-3-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-